Cutaneous lichen planus has been associated in patients with chronic hepatitis C virus infection. It is still unknown whether hepatitis C virus infects keratinocytes of lichen planus lesions. In this report we have analyzed the presence of genomic and antigenomic hepatitis C virus RNA in skin biopsies from 26 patients with chronic hepatitis C and healthy skin and from 24 patients with cutaneous lichen planus (®ve with and 19 without hepatitis C virus infection) by in situ hybridization. Hepatitis C virus RNA was detected in the keratinocytes of 69% of the patients with healthy skin and chronic hepatitis C, in 100% of the patients with lichen planus and hepatitis C virus infection, and in none of lichen planus patients without hepatitis C virus infection. The percentage of keratinocytes showing genomic or anti-genomic hepatitis C virus RNA was statistically lower (p < 0.01 in all cases) in patients with healthy skin (mean T SD: 5.7 T 3.5% and 2.7 T 3.1% of keratinocytes with genomic or anti-genomic hepatitis C virus RNA, respectively) than in those with lichen planus lesions (31.7 T 7.9% and 18.8 T 7.4%, mean T SD) or the unaffected adjacent skin (24.8 T 6.9% and 14.3 T 3.8%, mean T SD). In conclusion, we have demonstrated that hepatitis C virus infects keratinocytes from patients with lichen planus and hepatitis C virus infection.
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Chronic HCV infection causes a wide range of types of liver damage, ranging from mild chronic hepatitis to liver cirrhosis and hepatocellular carcinoma (Di Bisceglie, 1997) ; however, besides liver disease, chronic HCV infection is associated with several extrahepatic manifestations, with skin disorders frequently observed in these patients (Hadziyannis, 1998; Doutre, 1999) . In relation to these skin diseases, several epidemiologic studies have shown that lichen planus (LP) lesions are more prevalent in patients with chronic hepatitis C than in the general population (Nagao et al, 1995; Carrozzo et al, 1996) .
LP is a mucocutaneous disease of unknown etiology that may be caused by a cell-mediated immune response directed against induced antigenic changes in epidermal keratinocytes (Sugerman et al, 2000) . In a previous study, Mangia et al (1999) , using the reverse transcription±polymerase chain reaction (reverse transcription±PCR), were unable to detect HCV-RNA of anti-genomic polarity (as an indicator of HCV replication) in skin samples from patients with LP and chronic hepatitis C. By contrast, Erkek et al (2001) detected HCV-RNA by PCR in lesional skin biopsies from patients with chronic HCV infection and LP. Furthermore, we have recently reported that HCV infects oral mucosa epithelial cells from patients with oral LP and chronic HCV infection (Arrieta et al, 2000) . Thus, it must still be determined whether HCV infects keratinocytes from LP lesions.
For these reasons, in this study, we present the results of an in situ hybridization study on the presence of genomic and anti-genomic HCV-RNA in skin biopsies from patients with cutaneous LP and chronic hepatitis C compared with biopsies of healthy skin from patients with chronic HCV infection.
PATIENTS AND METHODS
Patients The presence of HCV-RNA of genomic and anti-genomic polarities was analyzed by in situ hybridization in paraf®n-embedded skin biopsies from three groups of patients. Group 1 Twenty-six patients (12 female/14 male; age: 42.54 T 12.38 y, mean T SD) with histologically proven chronic hepatitis C and healthy skin without LP. All patients were anti-HCV positive, and HCV-RNA was detectable in the serum of 23 of them. Seven patients had normal alanine aminotransferase (ALT) values (upper normal limit 40 IU per liter), whereas the remaining 19 patients had abnormal ALT levels (87.2 T 40.3 IU per liter, mean T SD). Group 2 Five patients (two female/three male; mean: 52 T 12.94 y, mean T SD) with cutaneous LP and chronic HCV infection. HCV-RNA was detectable in the serum of all ®ve patients but only one of them was anti-HCV positive. Four of the ®ve patients had normal ALT levels, whereas the other patient had abnormal ALT values (52 IU per liter). Group 3 Nineteen patients (10 female/nine male; age: 49.58 T 17.84 y, mean T SD) with cutaneous LP without markers of HCV infection (anti-HCV and HCV-RNA negative in serum), and with normal ALT values.
The inclusion criteria for patients from groups 2 and 3 were that there would be suf®cient paraf®n-embedded tissue to perform the in situ hybridization studies and that a serum sample obtained at the time of the skin biopsy properly stored at ±20°C would be available.
None of the patients were receiving anti-viral or immunosuppressive therapy when the skin biopsies were obtained. Other causes of liver disease, such as autoimmune hepatitis, coinfection with other hepatotropic viruses, etc., were excluded. Furthermore, all the patients included in this study were negative for the antibodies against the human immunode®ciency virus (anti-human immunode®ciency virus).
Skin biopsies from LP lesions and from the unaffected adjacent skin were obtained to con®rm the clinical diagnosis. After histologic examination, the remaining tissue was used for the in situ hybridization studies. The anatomical locations of the LP lesions in patients with and without chronic HCV infection are shown in Table I .
Skin samples from patients with healthy skin and chronic hepatitis C were obtained when the diagnostic liver biopsy was performed. Liver biopsies were obtained under ultrasonographic control and local anesthesia. At the biopsy needle penetration site (between the eighth or ninth intercostal space in the mid-axillary line), a 4 mm punch skin biopsy was performed. Obtaining the skin biopsy did not modify the procedure used to perform the liver biopsy.
The study was conducted in accordance with the guidelines of``Good Clinical Practice'' that underwrites the principles of the Declaration of Helsinki on human experimentation. Written informed consent was obtained from each patient participating in the study.
Serologic markers Anti-HCV was determined by a third-generation enzyme-linked immunoassay (INNOTEST HCV AbIII, Innogenetics, Heiden, Germany), and con®rmed by a recombinant immunoblot assay (INNO-LIA HCV AbIII, Innogenetics).
Hepatitis B virus surface antigen, antibodies against hepatitis B virus surface antigen, antibodies against hepatitis B core antigen, anti-hepatitis D virus, IgM anti-hepatitis A virus, and anti-human immunode®ciency virus were studied by commercial enzyme immunoassays (Roche Diagnostic Systems, Basel, Switzerland).
HCV-RNA quanti®cation and genotyping in serum samples HCV-RNA concentration in serum was determined using the Amplicor HCV Monitor Quantitative Assay (Roche Diagnostics Systems). HCV genotypes were determined with the INNO-LIPA HCV II test (Innogenetics NV, Zwjnaarde, Belgium).
In situ hybridization
Positive and negative polarity labeled HCV riboprobes were generated by in vitro transcription of the pC5¢NCR plasmid (that contains the cDNA corresponding to the complete 5¢ noncoding region of the HCV genome) in the presence of digoxigenin 11-uridine triphosphate (Roche Molecular Biochemicals, Indianapolis, IN). Dewaxed sections of the skin biopsies were hybridized with positive or negative polarity labeled probes to detect anti-genomic and genomic HCV-RNA, respectively, as previously described (Arrieta et al, 2001 ).
The in situ hybridization speci®city was assessed by: (i) hybridization with an unrelated probe (a 360 bp fragment of the chloramphenicol acetyl transferase gene, generated by PCR and cloned in the pCRII-TOPO vector); (ii) omission of the probe from the hybridization mixture; and (iii) digestions of the sections with RNase A (0.2 mg per ml) (Sigma, St Louis, MO) or DNase I (20 U per ml) (Sigma) for 2 h at 37°C prior to in situ hybridization.
The hybridization speci®city of the positive and negative polarity riboprobes with their complementary HCV-RNA was assessed by dot blot hybridization as described previously (Arrieta et al, 2001) .
Immunohistochemistry Immunohistochemical detection of HCV core antigen was performed in the skin biopsies from eight HCV-RNApositive and ®ve HCV-RNA-negative patients from whom enough paraf®n-embedded tissue was available to perform this technique.
Detection of the HCV core antigen was automatically performed (Tech Mate 500, Dako, Glostrup, Denmark) using an anti-HCV core monoclonal antibody (Hepatitis C virus Monotope TM , ViroStat, Portland, ME) at a 1 : 30 dilution after antigenic retrieval pressure cooking (3 min in 10 mM citrate buffer pH 6.0) using the Dako Envision staining procedure. The detection speci®city of the HCV core antigen was assessed by omitting the anti-HCV core antibody in the immunohistochemical detection in serial sections of the same skin biopsies.
As described above, immunohistochemical detection of the S-100 antigen (a marker of Langerhans dendritic cells) was also automatically performed in the same tissue sections that were previously employed for in situ hybridization using an anti-S-100 polyclonal antibody (Dako) at 1 : 2000 dilution.
Histologic diagnosis of LP lesions LP was histologically diagnosed when there was basal cell damage, lymphohistiocytic in®ltrate in a bandlike pattern with variable intraepithelial exocytosis, and the presence of homogeneous acidophilic bodies.
The severity of the in¯ammatory in®ltrate in hematoxylin±eosin-stained skin sections was scored from 1 to 3, depending on the intensity: 1 When the interphase between the dermis and the epidermis was preserved and the intensity of the in®ltrate was mild or focal in distribution in the papillar dermis. 2 When the interphase between the dermis and the epidermis was affected but had not disappeared, and the in®ltrate had a band-like disposition of moderate intensity. 3 When the interphase had disappeared and the density of the in®ltrate was severe.
Statistical analysis The Student's t test was used to analyze quantitative data and the Spearman correlation test for correlation. All pvalues are two-tailed; p < 0.05 was considered to indicate statistical signi®cance. All statistical analyses were performed using the SPSS package (SPSS for Windows release 9.0, SPSS Inc., Chicago, IL).
RESULTS
HCV-RNA in serum In group 1 (chronic hepatitis C patients with healthy skin), 23 of the 26 patients had HCV-RNA detectable in serum. The viremia levels in these patients ranged from 9.5 Q 10 3 IU per ml to 1.78 Q 10 6 IU per ml (4.91 Q 10 5 T 4.13 Q 10 5 IU per ml, mean T SD). In group 2 (patients with cutaneous LP and chronic HCV infection), the ®ve patients had detectable HCV-RNA in their serum at concentrations ranging from 10 3 IU per ml to 8.87 Q 10 5 (1.79 Q 10 5 T 3.95 Q 10 5 IU per ml, mean T SD). The fact that only one of the ®ve patients with cutaneous LP and HCV-RNA in serum had anti-HCV antibodies could indicate that these patients were immunosuppressed. All these patients, however, were anti-human immunode®ciency virus negative and their immunoglobulin levels and the leukocyte and lymphocyte counts were within the normal ranges (Table II) .
With respect to the HCV genotype, in group 1, 21 patients were infected by HCV 1b, one patient by HCV 1a, and the remaining patient was infected by the HCV 2a genotype. In group 2, the ®ve patients were infected by the HCV 1b genotype.
Detection of HCV-RNA in keratinocytes by in situ hybridization Positive hybridization signals were detected in keratinocyte cytoplasm of the basal, spinous, and granular layers of the epidermis in 18 of 26 (69.2%) of the skin biopsies from patients with chronic hepatitis C and healthy skin (group 1) and in ®ve of ®ve (100%) of the patients with LP and chronic HCV infection (group 2) in both the LP lesions as well as in the unaffected adjacent skin. No positive hybridization signals were observed in the skin biopsies from the 19 anti-HCV-negative, serum HCV-RNAnegative patients with cutaneous LP (group 3) (Fig 1) .
The speci®city of the in situ hybridization was further con®rmed by the lack of signals when the slides were hybridized with an unrelated probe, when the probe was omitted from the hybridization mix and when the slides were digested with RNase prior to hybridization. In contrast, no changes were observed in the hybridization patterns when the slides were predigested with DNase (Fig 2) .
Regarding the percentage of cells showing hybridization signals, HCV-RNA of genomic polarity was observed in 5.7 T 3.5% (mean T SD; range: 0.5±11.5%) of keratinocytes from patients with healthy skin and in 31.7 T 7.9% (mean T SD; range: 20± 40%) and in 24.8 T 6.9% (mean T SD; range: 17±35%) of the keratinocytes of LP lesions and the unaffected adjacent skin, respectively, from the patients with cutaneous LP. The differences in the percentages of keratinocytes showing genomic HCV-RNA in healthy skin and in LP lesions and the unaffected adjacent skin were statistically signi®cant (p = 0.001 and p = 0.003, respectively). Similarly, the percentages of keratinocytes showing anti-genomic HCV-RNA was signi®cantly lower (p = 0.007 and p = 0.001, respectively) in patients with healthy skin (mean T SD: 2.7 T 3.1%; range: 0.4±13.2%) than in LP lesions (mean T SD: 18.8 T 7.4%; range: 15±32%), and than in the unaffected adjacent skin (mean T SD: 14.3 T 3.8%; range 8±18%) ( Table III) .
The possibility of an unspeci®c hybridization between the positive polarity probe and the genomic HCV-RNA and the negative polarity probe and the anti-genomic viral RNA was discarded as no unspeci®c hybridization was detected by dot-blot hybridization (Fig 3) .
No statistical correlation was found between the percentage of keratinocytes showing HCV-RNA of genomic or anti-genomic polarities and the HCV viremia in patients with healthy skin or patients with LP.
Finally, no topologic correlation was observed between HCVinfected keratinocytes and the in¯ammatory in®ltrate in the LP lesions of the patients with chronic HCV infection.
Immunohistochemical detection of HCV core antigen and colocalization of HCV-RNA by in situ hybridization and the S-100 antigen by immunohistochemistry To con®rm further that HCV infects and replicates in keratinocytes, immunohistochemical detection of HCV core antigen was performed in skin sections from patients with and without HCV-RNA in serum. As shown in Fig 4, HCV core antigen was detected in the keratinocyte cytoplasm from HCV-RNA positive patients but not in the skin samples from the HCV-RNA negative cases.
In order to con®rm that the HCV-infected cells were keratinocytes and not dendritic (Langerhans) cells, immunohistochemical detection of the S-100 antigen was performed on the same slides used for the detection of HCV-RNA by in situ hybridization. As shown in Fig 5, the cells expressing the S-100 antigen were different from those showing HCV-RNA. Histologic damage in patients with LP and with or without HCV infection Regarding the intensity of the lymphocytic in®ltrate in patients with LP with and without HCV infection, three of ®ve (60%) patients with LP and HCV infection had an in¯ammatory in®ltrate of intensity 3, whereas this occurred in three of 19 (15.8%) patients with LP but without HCV infection. This difference did not reach statistical signi®cance (Table I) .
DISCUSSION
In this study we investigated the presence of HCV-RNA in keratinocytes from patients with chronic HCV infection with and without cutaneous LP. HCV-RNA of genomic and anti-genomic polarities was detected in the keratinocytes of 69% of patients with healthy skin and chronic hepatitis C and in 100% of the patients with cutaneous LP and chronic HCV infection. Viral infection of keratinocytes was also con®rmed by the detection of HCV core antigen in skin samples from patients with HCV-RNA in serum but not in the skin biopsies from the HCV-RNA negative cases. Viral infection of keratinocytes does not seem to be a special feature of HCV as it has been shown that another hepatotropic virus, the hepatitis B virus, is able to infect and replicate in keratinocytes (Mason et al, 1993) . Furthermore, it has been suggested that cytomegalovirus infection of skin keratinocytes may be implicated in the development of skin lesions in patients with systemic lupus erythematosus (Zhu, 1995) Table III. Percentage of infected keratinocytes and serum viremia levels in the chronic hepatitis C patients with LP (1±5) or with healthy skin (6±31) and Epstein±Barr virus infection of epithelial cells is associated with the appearance of oral hairy leukoplakia (Greenspan et al, 1985) . The percentage of keratinocytes showing hybridization signals corresponding to HCV-RNA of genomic and anti-genomic polarities was signi®cantly higher in LP patients (in both the LP lesion as well as in the unaffected adjacent skin) than in patients with normal skin. As photoexposed skin is immunosuppressed (Granstein, 1999) , it may be argued that the differences observed in the percentages of infected keratinocytes between patients with healthy skin and patients with LP was due to the fact that the skin biopsies from LP patients were obtained from a part of their body that had been exposed to light. This is not the case, however, as not only the skin samples from patients with healthy skin but also the biopsies from LP patients were obtained from body zones that are usually similarly photoexposed (the trunk in patients with healthy skin, and legs, arms, or trunk in LP patients).
On the other hand, it could be argued that hybridization signals are localized in the dendritic Langerhans cells and that they correspond to HCV particles phagocyted by these cells. When colocalization of HCV-RNA and the S-100 antigen were performed, however, the corresponding signals were observed in different cells.
Our results are in agreement with those reported by Erkek et al (2001) who detected HCV-RNA in skin biopsies from LP lesions in patients with chronic HCV infection; however, they differ from those obtained by Mangia et al (1999) who did not detect HCV-RNA of genomic and anti-genomic polarity using reverse transcription±PCR in cutaneous LP lesions from patients with chronic hepatitis C. The lack of detection of HCV-RNA by reverse transcription±PCR in skin biopsies in the report by Mangia et al may be explained by the time that elapsed between when the skin biopsies were obtained and when they were frozen. Thus, it has been reported that if liver biopsies are frozen in liquid nitrogen 5 min after they were obtained, HCV-RNA may be undetectable by reverse transcription±PCR due to the partial degradation of the viral RNA (Madejo Ân et al, 2000) . In fact, this effect should be more pronounced in skin biopsies than in liver biopsies, as the total amount of HCV-RNA in skin samples should be lower than in liver samples, in which up to 80% of hepatocytes may be infected by the virus (Agnello et al, 1998; Rodrõ Âguez-In Äigo et al, 1999) .
On the other hand, consistent with this study, in a previous report it was demonstrated the presence of HCV-RNA of positive and negative polarities in oral mucosa epithelial cells in oral LP lesions from patients with chronic hepatitis C (Arrieta et al, 2000) . In that report, however, the percentage of infected oral mucosa epithelial cells was similar in both the LP lesions and in healthy oral mucosa, whereas in this study, as mentioned earlier, the proportion of HCV-infected keratinocytes was signi®cantly higher in LP lesions than in healthy skin. We have no explanation for this discrepancy, although it may be speculated that oral mucosa epithelial cells produce different cellular factors that allow more ef®cient HCV infection in oral mucosa epithelial cells than in keratinocytes. This hypothesis requires testing in the future.
With respect to the implication of HCV infection of keratinocytes in the development of cutaneous LP, the fact that the percentage of HCV-infected keratinocytes was signi®cantly higher in LP lesions than in healthy skin suggests that HCV infection of keratinocytes may be involved in the pathogenesis of cutaneous LP. The fact that the percentage of infected keratinocytes in LP lesions (31.7 T 7.9%) was very similar to that found in the unaffected adjacent skin (24.8 T 6.9%), however, goes against this hypothesis. Nevertheless, our ®ndings in LP patients suggest that HCV infection of keratinocytes may contribute to the development of LP lesions in patients with chronic HCV infection. On the other hand, it is also possible that an unidenti®ed host factor of patients with LP may facilitate the infection and propagation of the virus in keratinocytes from these patients. In this sense, as only one of the ®ve patients with LP and HCV infection had detectable anti-HCV antibodies, it may be speculated that these patients may have an immunologic defect that facilitates HCV infection of keratinocytes. None of these patients, however, showed clinical or analytical evidence of immunosuppression. Furthermore, in the only patient with cutaneous LP and anti-HCV detectable in serum the percentage of infected keratinocytes (40%) was similar to that found in the four anti-HCV-negative cases (20±38%). Further research is needed to establish whether the presence of circulating anti-HCV in patients with LP does or does not modify the pattern of HCV infection of keratinocytes.
On the other hand, it has been previously shown that HCV is associated with very low-density lipoproteins in type II cryoglobulins (Agnello, 1997) and that HCV may infect cells via the lowdensity lipoprotein receptor (Agnello et al, 1999) . As these receptors are upregulated in keratinocytes from in¯ammatory skin lesions (Agnello and Abel, 1997) , the higher proportion of infected keratinocytes observed in LP lesions compared with that in healthy skin may be an epiphenomenon related to the greater expression of low-density lipoprotein receptors in keratinocytes from cutaneous LP lesions than in healthy skin. This hypothesis requires con®rm-ation through the analysis of patients with chronic HCV infection who also have other in¯ammatory skin diseases that are not associated with the HCV infection, such as psoriasis.
With respect to the severity of LP lesions in patients with and without HCV infection, in this study we have observed that, whereas 60% of the patients with LP and chronic HCV infection had a degree 3 in¯ammatory in®ltrate, this occurred in only 16% of the patients with cutaneous LP without HCV infection. This suggests that HCV infection of keratinocytes may increase the severity of cutaneous LP lesions by a currently unidenti®ed mechanism. This clearly warrants further investigation.
In conclusion, in this study we have demonstrated that HCV infects keratinocytes from cutaneous LP lesions and that the viral RNA is translated in these cells as demonstrated by the detection of HCV core protein in the skin biopsies. Although, however, we have detected HCV-RNA of negative polarity (which is usually accepted as an indicator of HCV replication), we cannot af®rm that HCV replicates in keratinocytes, as the negative polarity viral RNA may be the result of an abortive transcription of the HCV-RNA. So, further studies are needed to provide direct evidence of HCV replication in keratinocytes. On the other hand, the percentage of HCV-infected keratinocytes in patients with chronic hepatitis C was signi®cantly higher in patients with cutaneous LP than in patients with healthy skin. This ®nding suggests that HCV infection of keratinocytes is involved in the pathogenesis of cutaneous LP in patients with chronic HCV infection; however, more studies are required to con®rm this hypothesis.
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